Severe health-care-associated infections and antimicrobial resistance in an Asian Surveillance Network (ACORN-HAI): a multicentre, prospective cohort study.

Authors

Yin Mo, Xinxin Hao, Ying Ding, Yang Cao, Yiying Cai, Suwatthiya Kitsaran, Hock Hin Chua, Sotharith Bory, Sasheela Sri La Sri Ponnampalavanar, Siriluck Anunnatsiri, Mohd Zulfakar Mazlan, Azizullah Khan Dhiloo, Rongpong Plongla, Andrea Lay-Hoon Kwa, Syed Faisal Mahmood, Arthur Dessi Roman, Louise Thwaites, Phan Vinh Tho, Sheng Wu, Darunee Chotiprasitsakul, Ke Juin Wong, Hendri Wijaya, Cybele L Abad, Muhammad Osama Rehman Khalid, Gazi Md Salahuddin Mamun, Giri Shan Rajahram, Helio Guterres, Huynh Ngoc Hon, Ngoc Thach Pham, Van Giang Tran, Abhilasha Karkey, Samanmalee Gunasekara, Raph L Hamers, Robert Sinto, Inke Nadia D Lubis, Minggui Wang, Merlin Moni, Po-Yu Liu, Yonghong Xiao, Basudha Khanal, N Lakshmi Priya, Yohei Doi, Hitoshi Honda, Bayaraa Baljin, Rosmonaliza Asli, Ulziijargal Gurjav, Lowell Ling, Ashesh Dhungana, Li Yang Hsu, David Leslie Paterson, ACORN-HAI investigators

Published in

The Lancet. Infectious diseases. Aug 21, 2026. Epub Aug 21, 2026.

Abstract

Antimicrobial resistance (AMR) poses a major global health threat, with health-care-associated infections contributing substantially to mortality. Attributable disease burden remains poorly quantified by relying on cross-sectional and microbiology data. We aimed to characterise AMR epidemiology and disease burden associated with ventilator-associated pneumonia and bloodstream infection in a network of hospitals in Asia.
This large-scale, prospective, multinational, multicentre cohort study consecutively enrolled patients of any age with microbiologically-confirmed ventilator-associated pneumonia, hospital-acquired bloodstream infections, or health-care-associated bloodstream infections from 41 selected hospitals capable of standardised prospective data collection in 19 Asian countries and regions. Patients with pathogens typically associated with community-acquired infection or not recognised causes of health-care-associated infection were excluded according to predefined protocol criteria, and patients were followed for 28 days. The primary outcome was 28-day mortality from infection onset. Pathogen profiles, antimicrobial prescriptions, attributable mortality, and health-related quality-of-life outcomes were analysed.
Between Sept 1, 2022, and Feb 28, 2025, 10 111 patients were enrolled, and after exclusions, 9496 patients were included in the final analysis. 9642 infection episodes were analysed, comprising 6597 (68·4%) bloodstream infections and 3045 (31·6%) ventilator-associated pneumonia. Of these infections, 7102 (73·7%) of 9642 infection episodes were associated with AMR bacteria, and Gram-negative bacteria were predominant (7599 [78·8%]). Crude 28-day mortality was 2674 (37·7%) of 7102 AMR infection episodes and 1900 (40·6%) of 4683 multidrug resistance infection episodes, with the highest for carbapenem-resistant Acinetobacter spp (CRA; 51·3%) and carbapenem-resistant Enterobacterales (CRE; 48·4%). AMR-attributable mortality was the highest in ventilator-associated pneumonia (16·9%, 95% CI 13·0-20·9), individuals aged 5-14 years (11·7%, 95% CI 1·6-21·8), individuals aged 15-49 years (11·2%, 95% CI 7·2-15·2), and lower-middle-income countries (10·7%, 95% CI 7·0-14·4). By pathogens, CRA and CRE had the highest attributable mortality (19·4%, 95% CI 14·1-24·7 vs 16·2%, 95% CI 12·8-19·6) and also had the poorest quality-of-life outcomes. Most carbapenem-resistant Gram-negative infections were treated with carbapenems (57·8%) or polymyxins (35·6%).
AMR bacterial bloodstream infections and ventilator-associated pneumonia were common and associated with high mortality and reduced quality of life in Asia, particularly in infections due to carbapenem-resistant Acinetobacter spp and CRE, and among children and younger adults. The widespread use of suboptimal antimicrobial regimens highlights the urgent need for equitable access to effective therapies and context-specific evidence to guide antimicrobial stewardship.
Wellcome Trust, National University of Singapore, Yong Loo Lin School of Medicine, Duke-NUS Medical School, Nanyang Technological University (Lee Kong Chian School of Medicine), Singapore National Centre for Infectious Diseases, and Singapore Medical Research Council.

PMID:
42628558
Bibliographic data and abstract were imported from PubMed on 22 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.